Amit Kuma

Oct 25, 2024 | better.net | Marie Rossiter |Susan Berger |Amit Kuma

An exciting clinical trial involving a vaccine at the Cleveland Clinic could change the world of breast cancer. “Curing cancer has been something we all talk about. Even better, is to prevent the cancer in the first place. So, in a sense, prevention is the cure,” said Dr. Amit Kumar, CEO of Anixa Biosciences. An early-stage clinical trial for a breast cancer vaccine is yielding remarkable results.